Scientific Advisory Board
What STAR Is
Press Releases and News
The result of years of research, our flagship STAR® technology provides substrate independent, precision engineered, 3D biomaterial scaffolds that enhance the biocompatibility of existing and next generation medical devices.
Healionics’ Adrienne Oda in Forbes magazine’s “30 Under 30“
Healionics Today Announced the Appointment of Mike Connolly as Chief Executive Officer
Healionics Awarded $1.5M SBIR Grant from NIH to Advance Clot-Resistant Synthetic Vascular Graft for Dialysis Patients
Media & Events
© 2009-2016 Healionics. All rights reserved. U.S. Patent No. 7,972,628. Other U.S. and Foreign Patents Granted or Pending.
These Products are for Research Use Only. Not intended for any animal or human therapeutic or diagnostic use unless otherwise stated.